Health Legislation Amendment (Improving Choice and Transparency for Private Health Consumers) Bill 2026: what it would change and who it would affect

The short answer

Health Legislation Amendment (Improving Choice and Transparency for Private Health Consumers) Bill 2026: what it would change and who it would affect

The Health Legislation Amendment (Improving Choice and Transparency for Private Health Consumers) Bill 2026 is a government bill introduced in the House of Representatives on 12 February 2026 by the Albanese Government. It proposes two significant changes to the regulation of Australia's private health system: first, it would enable the public release of data about what individual medical specialists actually charge for procedures, along with estimates of likely out-of-pocket costs; second, it would require private health insurers to seek ministerial approval before increasing their premiums. The bill amends the Health Insurance Act 1973 and the Private Health Insurance Act 2007. It passed the House of Representatives and is currently before the Senate, where it has been referred to the Senate Community Affairs Legislation Committee for inquiry, with a report originally due by 15 April 2026. As of July 2026, the bill had not yet passed the Senate and had not become law. The first major component of the bill deals with medical fee transparency. Under current law, there is no comprehensive public database showing what individual specialists charge for specific procedures. While Medicare publishes aggregate statistics on bulk-billing rates and average fees at a regional level, patients typically cannot compare the gap fees charged by different specialists before booking a consultation or proceeding with surgery. This information asymmetry is widely acknowledged as a driver of unexpected out-of-pocket costs, sometimes running to thousands of dollars, which patients only learn about after treatment. The bill proposes to amend the Health Insurance Act 1973 to authorise the collection and publication of information on medical fees charged by medical practitioners. It would also amend the Private Health Insurance Act 2007 to enable the publication of likely out-of-pocket costs associated with particular procedures and practitioners. The published information is intended to allow consumers to compare costs between different specialists before committing to treatment. This could be particularly valuable for elective surgeries such as orthopaedic procedures, cataract surgery, and obstetrics, where out-of-pocket costs vary significantly between practitioners even within the same geographic area. The second major component would change how private health insurance premiums are set. Currently, insurers submit proposed premium increases to the Department of Health and Aged Care annually. The minister can request that insurers revise their proposals, and there is a negotiation process. However, there is no explicit statutory power to reject a proposed increase outright — the current system relies on a combination of ministerial persuasion, public pressure, and the threat of adverse publicity if increases are deemed excessive. Under the bill, the Private Health Insurance Act 2007 would be amended so that private health insurers must apply to the minister for approval before changing the premiums charged under a complying health insurance product. The minister would be given the explicit statutory power to approve or refuse a premium change, shifting from a consultative model to an approval-based model. The bill was scrutinised by the Senate Standing Committee for the Scrutiny of Bills, which reported in Scrutiny Digest 3 of 2026 on 25 February 2026. The scrutiny committee typically examines bills for compliance with principles of personal rights, parliamentary oversight, and the rule of law. It may have raised concerns about the breadth of delegated legislative power in setting fee publication rules, potential privacy implications of publishing practitioner-level fee data, or the absence of specified criteria for the minister's premium approval decisions. The bill has also been examined by the Senate Community Affairs Legislation Committee following referral on 5 March 2026, which provides a forum for stakeholder evidence from consumer groups, medical organisations, insurers, and health economists. Who would be affected: The bill affects several groups. For consumers with private health insurance — approximately 14.7 million Australians — the proposed fee transparency measures could provide significantly better information when choosing specialists, potentially reducing unexpected out-of-pocket costs. The Grattan Institute and the Consumers Health Forum have long advocated for greater transparency in medical fees, arguing it is a fundamental consumer right in a market where patients currently make decisions with incomplete information. However, the actual impact depends on whether publication of fees leads to genuine price competition or simply greater awareness of existing gaps without changing behaviour. For medical specialists, the bill would create new reporting obligations and public scrutiny of their fee-setting practices. The Australian Medical Association has historically expressed caution about fee transparency measures, arguing that raw fee data without clinical context about case complexity, patient comorbidities or procedural difficulty can be misleading and may unfairly penalise specialists who take on more complex cases. For private health insurers, the premium approval requirement represents a material constraint on their commercial pricing decisions. Insurers argue that premium increases reflect underlying healthcare cost inflation, including rising hospital charges, device costs, and utilisation rates, and that constraining premiums without addressing cost drivers could affect insurer solvency or the breadth of coverage over time. Important uncertainties remain. The bill does not specify the exact format or level of detail in which fee information will be published. Critical implementation questions include: will the published data identify individual specialists by name or will it be de-identified or aggregated by region? Will it include Medicare Benefits Schedule (MBS) item numbers to allow comparison of fees for specific procedures? Will it include information about the hospital or day surgery where the procedure was performed? Will it distinguish between in-hospital and out-of-hospital services? The bill defers these questions to regulation, meaning Parliament will not directly debate or vote on the implementation details. The bill also does not specify the criteria the minister would use when deciding whether to approve or reject a premium increase, leaving significant discretion to the executive. Different health ministers could apply different standards. The Parliamentary Library's Bills Digest, which is available for this bill, provides independent analysis of the bill's provisions, context and potential issues. The Senate committee inquiry will also have generated submissions and evidence that address many of the uncertainties identified here. The next steps for the bill are: the Senate Community Affairs Legislation Committee inquiry report, debate in the Senate including a second reading vote, possible amendments proposed by senators or the government, and if passed with amendments, return to the House of Representatives for concurrence on any amendments. If passed by both houses in identical form, the bill would be presented to the Governor-General for royal assent. The operative provisions would commence on a date to be fixed by proclamation, or six months after royal assent if no proclamation is made earlier. It is important to distinguish what the bill proposes from what has been claimed in political debate. The government has presented the bill as delivering greater transparency and consumer choice in private health. Whether fee publication would meaningfully change consumer behaviour, referral patterns, or specialist pricing is genuinely uncertain — it depends on factors including how the data is presented, whether consumers and referring GPs actively use it, and whether there is sufficient competition among specialists in a given geographic area and specialty. The premium approval power gives the government a direct regulatory lever over insurance costs, but could also be characterised as a form of price control that would need to be exercised carefully to avoid unintended consequences for insurer viability, product innovation, or coverage levels in the longer term. The bill should be understood as a framework that sets the direction of policy; its real-world impact will be largely determined by the regulations and administrative practices that follow if it passes.

This is a federal system guide. State constitutions, parliaments and local-government laws can allocate comparable functions differently.

The useful question is not only “what is the rule?” but also “who administers it, which document controls it, and when might it change?” That distinction prevents an accurate general explanation from becoming wrong advice in a particular election, chamber or policy setting.

Evidence review

What the bill proposes

The Health Legislation Amendment (Improving Choice and Transparency for Private Health Consumers) Bill 2026 is a government bill introduced on 12 February 2026. It amends two Acts: the Health Insurance Act 1973 and the Private Health Insurance Act 2007.

It has two main components. The first would enable the government to collect and publish information about what individual medical specialists charge for procedures, and to publish estimates of likely out-of-pocket costs for consumers. The second would require private health insurers to apply to the minister for approval before they can increase premiums on complying health insurance products.

The bill passed the House of Representatives and moved to the Senate, where it is currently under consideration. It was referred to the Senate Community Affairs Legislation Committee for inquiry on 5 March 2026.

Evidence review

Medical fee transparency

Under current law, there is no comprehensive public database showing what individual medical specialists charge for particular procedures. While Medicare publishes aggregate statistics on bulk-billing rates and average fees at a regional level, patients typically cannot compare the gap fees charged by different specialists before booking a consultation or procedure.

The bill would amend the Health Insurance Act 1973 to authorise the collection and publication of information on 'medical fees charged by medical practitioners'. It would also amend the Private Health Insurance Act 2007 to enable the publication of 'likely out-of-pocket costs'. The precise format, level of detail, and frequency of publication would be set by regulation, which means Parliament would not directly debate these implementation details.

The intended effect is to give consumers — and particularly those with private health insurance — the ability to compare costs between specialists before committing to treatment. The extent to which this occurs will depend on whether the published data is granular enough to be useful (e.g. by procedure code, by specialist, by hospital) and whether patients and referring GPs actively use the information.

Evidence review

Premium approval powers

Currently, private health insurers submit their proposed annual premium increases to the Department of Health and Aged Care for assessment. The minister can request that insurers revise their proposals, and there is a negotiation process, but the minister does not have an explicit statutory power to reject a proposed increase outright.

The bill would amend the Private Health Insurance Act 2007 to require private health insurers to 'apply to the minister for approval to change the premiums charged under a complying health insurance product'. The minister would have the power to approve or refuse a proposed change. This formalises the government's role and gives the minister a direct regulatory lever over premium pricing.

The bill does not specify the criteria the minister must use when deciding on premium applications. This leaves significant discretion to the minister of the day and could mean different approaches from different governments.

Evidence review

What happened in Parliament

The bill was introduced in the House of Representatives on 12 February 2026 and the second reading was moved the same day. It subsequently passed the House. The Senate Standing Committee for the Scrutiny of Bills considered the bill and reported in Scrutiny Digest 3 of 2026 on 25 February 2026. The bill was referred to the Senate Community Affairs Legislation Committee on 5 March 2026, with the committee's report originally due by 15 April 2026.

As of July 2026, the bill remains before the Senate. No proposed amendments had been circulated at the time of the March 2026 archival snapshot, though amendments may have been filed since.

Evidence review

Who would be affected

The bill would affect several distinct groups. Medical practitioners — particularly specialists and surgeons who charge fees above the Medicare Benefits Schedule — would have their fees and out-of-pocket costs published. This could influence how patients choose specialists and may place competitive pressure on practitioners who charge significantly above the market rate for particular procedures.

Private health insurance consumers would be the primary beneficiaries. The bill is designed to give consumers better information about likely out-of-pocket costs before they undergo a procedure, addressing a long-standing complaint that patients often discover the gap between what Medicare and their insurer covers and what their specialist charges only after receiving treatment. The premium approval changes would affect all 14 million Australians with private health insurance by giving the minister additional grounds to scrutinise and reject premium increases.

Private health insurers would face a changed regulatory environment. Under the bill, insurers would be required to apply for ministerial approval before changing premiums, with the minister able to consider the insurer's financial performance, capital adequacy and the impact on consumers when deciding whether to approve an increase. This represents a shift from the existing framework where premium changes are negotiated between the Department of Health and insurers. The government, through the Health Minister, would gain expanded regulatory powers over the private health insurance market.

Evidence review

Remaining steps and uncertainties

The bill must pass the Senate and, if amended, return to the House for concurrence on any amendments. It must then receive royal assent. The operative provisions would commence on a date to be fixed by proclamation or six months after assent.

Many operational details would be determined by regulation rather than the bill text itself — including the format of published fee data, the level of detail, and the criteria for approving or rejecting premium changes. These regulatory decisions will significantly shape the real-world impact of the legislation.

The Parliamentary Library's Bills Digest provides independent analysis that may identify additional issues including potential unintended consequences, privacy concerns, and the interaction with existing regulatory frameworks.

Evidence review

Chamber record cross-check — 2 July 2026

Senate Dynamic Red listed Health Legislation Amendment (Improving Choice and Transparency for Private Health Consumers) Bill 2026 on 2026-07-02. The working chamber record described the position as “listed for Senate consideration or debate”. Dynamic Red is a same-sitting record and can change as proceedings continue; the corrected Hansard and current bill page control the final procedural account. For Health Legislation Amendment (Improving Choice and Transparency for Private Health Consumers) Bill 2026, this date-specific entry should therefore be treated as a procedural snapshot rather than a final status, and checked against the later settled record before drawing a conclusion.

Common questions

Before you rely on the answer